AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47

Authors: Harris, A Levy, E Kanal, E Pollack, A Cayhill, AM Omalu, BI Albright, AL
Citation: A. Harris et al., Infectious aneurysm clipping by an MRI/MRA wand-guided protocol - A case report and technical note, PED NEUROS, 35(2), 2001, pp. 90-93

Authors: Pollack, A
Citation: A. Pollack, Evidence for cure of 'young' men with prostate cancer - The Hanks/Hanlon/Horwitz article reviewed, ONCOLOGY-NY, 15(5), 2001, pp. 571-572

Authors: Pollack, A Salem, N Ashoori, F Hachem, P Sangha, M von Eschenbach, AC Meistrich, ML
Citation: A. Pollack et al., Lack of prostate cancer radiosensitization by androgen deprivation, INT J RAD O, 51(4), 2001, pp. 1002-1007

Authors: Zagars, GK Pollack, A
Citation: Gk. Zagars et A. Pollack, Radiotherapy for Stage II testicular seminoma, INT J RAD O, 51(3), 2001, pp. 643-649

Authors: Starkschall, G Pollack, A Stevens, CW
Citation: G. Starkschall et al., Treatment planning using a dose-volume feasibility search algorithm, INT J RAD O, 49(5), 2001, pp. 1419-1427

Authors: Pollack, A
Citation: A. Pollack, Generic drugs competing with biotech products, BIOFUTUR, 2001(210), 2001, pp. 43-45

Authors: Goldie, SJ Kuhn, L Denny, L Pollack, A Wright, TC
Citation: Sj. Goldie et al., Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness (vol 285, pg 3107, 2001), J AM MED A, 286(9), 2001, pp. 1026-1026

Authors: Goldie, SJ Kuhn, L DennY, L Pollack, A Wright, TC
Citation: Sj. Goldie et al., Policy analysis of cervical cancer screening strategies in low-resource settings - Clinical benefits and cost-effectiveness, J AM MED A, 285(24), 2001, pp. 3107-3115

Authors: Zagars, GK Pollack, A von Eschenbach, AC
Citation: Gk. Zagars et al., Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer, UROLOGY, 58(2), 2001, pp. 233-239

Authors: Campbell, T Blasko, J Crawford, ED Forman, J Hanks, G Kuban, D Montie, J Moul, J Pollack, A Raghavan, D Ray, P Roach, M Steinberg, G Stone, N Thompson, I Vogelzang, N Vijayakumar, S
Citation: T. Campbell et al., Clinical staging of prostate cancer: Reproducibility and clarification of issues, INT J CANC, 96(3), 2001, pp. 198-209

Authors: Kuhn, L Denny, L Pollack, A Lorincz, A Richart, RM Wright, TC
Citation: L. Kuhn et al., Human papillomavirus DNA testing for cervical cancer screening in low-resource settings, J NAT CANC, 92(10), 2000, pp. 818-825

Authors: May, CA Tamaki, K Neumann, R Wilson, G Zagars, G Pollack, A Dubrova, YE Jeffreys, AJ Meistrich, ML
Citation: Ca. May et al., Minisatellite mutation frequency in human sperm following radiotherapy, MUT RES-F M, 453(1), 2000, pp. 67-75

Authors: Milstein, A Barak, Y Kleinman, G Pollack, A
Citation: A. Milstein et al., The incidence of delirium immediately following cataract removal surgery: a prospective study in the elderly, AGING MENT, 4(2), 2000, pp. 178-181

Authors: Raut, A Huryn, J Pollack, A Zlotolow, I
Citation: A. Raut et al., Unusual gingival presentation of post-transplantation lymphoproliferative disorder: A case report and review of the literature, ORAL SURG O, 90(4), 2000, pp. 436-441

Authors: Kelly, JF Pollack, A Zagars, GK
Citation: Jf. Kelly et al., Serum testosterone is not a correlate of prostate cancer lymph node involvement, but does predict biochemical failure for lymph node positive disease, UROL ONCOL, 5(2), 2000, pp. 78-84

Authors: Cowen, D Salem, N Ashoori, F Meyn, R Meistrich, ML Roth, JA Pollack, A
Citation: D. Cowen et al., Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy, CLIN CANC R, 6(11), 2000, pp. 4402-4408

Authors: Amato, RJ Millikan, R Daliani, D Wood, L Logothetis, C Pollack, A
Citation: Rj. Amato et al., Cyclophosphamide and carboplatin and selective consolidation in advanced seminoma, CLIN CANC R, 6(1), 2000, pp. 72-77

Authors: Leiba, H Rachmiel, R Harris, A Kagemann, L Pollack, A Zalish, M
Citation: H. Leiba et al., Optic nerve head blood flow measurements in non-arteritic anterior ischaemic optic neuropathy, EYE, 14, 2000, pp. 828-833

Authors: Pollack, A Zagars, GK Smith, LG Lee, JJ von Eschenbach, AC Antolak, JA Starkschall, G Rosen, I
Citation: A. Pollack et al., Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer, J CL ONCOL, 18(23), 2000, pp. 3904-3911

Authors: Colletier, PJ Ashoori, F Cowen, D Meyn, RE Tofilon, P Meistrich, ME Pollack, A
Citation: Pj. Colletier et al., Adenoviral-mediated p53 transgene expression sensitizes both wild-type andnull p53 prostate cancer cells in vitro to radiation, INT J RAD O, 48(5), 2000, pp. 1507-1512

Authors: Storey, MR Pollack, A Zagars, G Smith, L Antolak, J Rosen, I
Citation: Mr. Storey et al., Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial, INT J RAD O, 48(3), 2000, pp. 635-642

Authors: Pollack, A Smith, LG von Eschenbach, AC
Citation: A. Pollack et al., External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era, INT J RAD O, 48(2), 2000, pp. 507-512

Authors: Pollack, A Ashoori, F Sikes, C Joon, DL von Eschenbach, AC Zagars, GK Meistrich, ML
Citation: A. Pollack et al., The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions, INT J RAD O, 46(1), 2000, pp. 153-158

Authors: White, RA Meistrich, ML Pollack, A Terry, NHA
Citation: Ra. White et al., Simultaneous estimation of TG2+M, T-S, and T-pot using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry, CYTOMETRY, 41(1), 2000, pp. 1-8

Authors: Wright, TC Denny, L Kuhn, L Pollack, A Lorincz, A
Citation: Tc. Wright et al., HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer, J AM MED A, 283(1), 2000, pp. 81-86
Risultati: 1-25 | 26-47